These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23752219)

  • 61. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of Medicare prescription drug coverage on the use of antidementia drugs.
    Fowler NR; Chen YF; Thurton CA; Men A; Rodriguez EG; Donohue JM
    BMC Geriatr; 2013 Apr; 13():37. PubMed ID: 23621892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medicare Part D and quality of prescription medication use in older adults.
    Lau DT; Briesacher BA; Touchette DR; Stubbings J; Ng JH
    Drugs Aging; 2011 Oct; 28(10):797-807. PubMed ID: 21970307
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug use patterns in severely mentally ill Medicare beneficiaries: impact of discontinuities in drug coverage.
    Simoni-Wastila L; Zuckerman IH; Shaffer T; Blanchette CM; Stuart B
    Health Serv Res; 2008 Apr; 43(2):496-514. PubMed ID: 18370965
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subsidies for Oral Chemotherapy and Use of Immunomodulatory Drugs Among Medicare Beneficiaries With Myeloma.
    Olszewski AJ; Dusetzina SB; Eaton CB; Davidoff AJ; Trivedi AN
    J Clin Oncol; 2017 Oct; 35(29):3306-3314. PubMed ID: 28541791
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.
    Glynn A; Hernandez I; Roberts ET
    Health Serv Res; 2022 Oct; 57(5):1136-1144. PubMed ID: 35430735
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.
    Tseng CW; Dudley RA; Chen R; Walensky RP
    JAMA Netw Open; 2020 Apr; 3(4):e202739. PubMed ID: 32286656
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Digesting the doughnut hole.
    Joyce GF; Zissimopoulos J; Goldman DP
    J Health Econ; 2013 Dec; 32(6):1345-55. PubMed ID: 24308883
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Growing Number Of Unsubsidized Part D Beneficiaries With Catastrophic Spending Suggests Need For An Out-Of-Pocket Cap.
    Trish E; Xu J; Joyce G
    Health Aff (Millwood); 2018 Jul; 37(7):1048-1056. PubMed ID: 29985706
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.
    Sacks NC; Burgess JF; Cabral HJ; Pizer SD; McDonnell ME
    J Gen Intern Med; 2013 Jul; 28(7):876-85. PubMed ID: 23404199
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.
    Jiang Y; Ni W
    Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes.
    Choi YJ; Jia H; Gross T; Weinger K; Stone PW; Smaldone AM
    Diabetes Care; 2017 Apr; 40(4):502-508. PubMed ID: 27803119
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs.
    Jung K; McBean AM; Kim JA
    J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recent proposals to limit Medigap coverage and modify Medicare cost sharing.
    Linehan K
    Issue Brief George Wash Univ Natl Health Policy Forum; 2012 Feb; (845):1-19. PubMed ID: 22420066
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia.
    MacEwan JP; Forma FM; Shafrin J; Hatch A; Lakdawalla DN; Lindenmayer JP
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1349-1361. PubMed ID: 27783548
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder.
    Zhang Y; Adams AS; Ross-Degnan D; Zhang F; Soumerai SB
    Psychiatr Serv; 2009 Apr; 60(4):520-7. PubMed ID: 19339328
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of an expenditure cap on low-income seniors' drug use and spending in a state pharmacy assistance program.
    Bishop CE; Ryan AM; Gilden DM; Kubisiak J; Thomas CP
    Health Serv Res; 2009 Jun; 44(3):1010-28. PubMed ID: 19291168
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Geographic variation in medication adherence in commercial and Medicare part D populations.
    Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T
    J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medicare Part D coverage gap and diabetes beneficiaries.
    Schmittdiel JA; Ettner SL; Fung V; Huang J; Turk N; Quiter ES; Swain BE; Hsu JT; Mangione CM
    Am J Manag Care; 2009 Mar; 15(3):189-93. PubMed ID: 19298100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.